<DOC>
	<DOCNO>NCT01414192</DOCNO>
	<brief_summary>This study do provide valid data evolution cohort French participant treat ezetimibe , alone combination statin , use simulation model cardiovascular disease ( CVD ) . Patterns drug use , evolution risk factor CVD , cardiovascular morbidity mortality , goal attainment low density lipoprotein cholesterol ( LDL-C ) level time analyze .</brief_summary>
	<brief_title>A Study Design Model Cohort Analysis Dyslipidemia ( MK-0653A-204 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Inclusion criterion : Resident Continental France Treated ezetimibe either monotherapy ( Ezetrol® ) , coadministered statin administer fix combination ezetimibe simvastatin ( Inegy® ) Incident treatment ezetimibe time recruitment study Exclusion criterion : Unlikely followedup next 6 month recruitment due plan change residence Participating clinical trial Unable read information letter French and/or unable participate telephone interview French</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>